Healthcare

Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.

Drug giant Sanofi has failed in its appeal of a decision granting applications by biopharmaceutical company Amgen for patents covering the cholesterol-lowering treatment Repatha.

Real estate landlord Dexus is suing South Australia's medical research insitute for failing to execute on 30-year leases to occupy Adelaide's Australian Bragg Centre, despite "repeated demands".

Medibank has been ordered to give a class action copies of reports by Deloitte into a massive data breach in October 2022, in a judgment made public on Friday and already facing appeal by the health insurer.

A unit of collapsed start-up StrongRoom AI has warned creditors of its parent company that recent freezing orders need to be tweaked to allow it to continue trading, or there may be little money left to argue over. 

The builder contracted to carry out expansion works at Casey Hospital in Berwick has sued its insurer for refusing to cover $4 million in damages caused by a subcontractor's delays.

A class action over alleged botched cosmetic surgeries can drop claims against one surgeon, but the doctor will remain a party so other defendants can point the finger at him.

US lab products giant Beckman Coulter has successfully opposed an Australian biotech's bid to trade mark ‘Cytophex’ for its stem cell expansion system, with an IP Australia delegate finding the mark is too similar to Beckman's ‘CytoFLEX’ mark. 

The ACT government’s has appointed Multiplex to support design and planning work for the next stage of the territory's northside hospital project in Canberra.

A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.